The goal is to develop a minimally invasive technique that, using our malleable, highly conductive electro-material, both removes tumours and trains the immune system in real time. By injecting the hydrogel in situ, we can fight cancer more effectively and gently for the patient. The aim of this specific grant is to protect the rights of the unique material.
